PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+7.64%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.2B
AUM Growth
-$263M
(-18%)
Cap. Flow
-$322M
Cap. Flow
% of AUM
-26.78%
Top 10 Holdings %
Top 10 Hldgs %
18.87%
Holding
1,434
New
335
Increased
266
Reduced
268
Closed
401
Top Buys
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.2M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.86M |
| 3 |
NetEase
NTES
|
+$7.51M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$7.42M |
| 5 |
Micron Technology
MU
|
+$6.83M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$68.7M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$65.7M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.3M |
| 5 |
Alibaba
BABA
|
+$10.3M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Healthcare | 11.57% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Asana
ASAN
$3.14B
| $343K | 0.02% |
15,568
-9,581
| -38% | -$211K |
|
502
Idexx Laboratories
IDXX
$51B
| $339K | 0.02% |
675
-66
| -9% | -$33.1K |
|
503
Silicom
SILC
$101M
| $337K | 0.02% |
9,152
-5,144
| -36% | -$190K |
|
504
Sabesp
SBS
$15.8B
| $337K | 0.02% |
28,452
-207
| -0.7% | -$2.45K |
|
505
Herc Holdings
HRI
$4.43B
| $335K | 0.02% |
2,451
+577
| +31% | +$79K |
|
506
Pfizer
PFE
$140B
| $335K | 0.02% |
9,123
+1,837
| +25% | +$67.4K |
|
507
Apogee Enterprises
APOG
$896M
| $333K | 0.02% |
7,023
-6,036
| -46% | -$287K |
|
508
Legend Biotech
LEGN
$6.18B
| $333K | 0.02% |
4,822
-11,178
| -70% | -$772K |
|
509
IDEX
IEX
$12.1B
| $332K | 0.02% |
1,542
+87
| +6% | +$18.7K |
|
510
Hyatt Hotels
H
$13.6B
| $332K | 0.02% |
+2,896
| New | +$332K |
|
511
NXP Semiconductors
NXPI
$55.3B
| $330K | 0.02% |
1,610
+284
| +21% | +$58.1K |
|
512
Bioceres Crop Solutions
BIOX
$124M
| $329K | 0.02% |
24,631
-10,173
| -29% | -$136K |
|
513
BridgeBio Pharma
BBIO
$10.1B
| $328K | 0.02% |
19,041
+3,764
| +25% | +$64.7K |
|
514
Allison Transmission
ALSN
$7.41B
| $327K | 0.02% |
5,800
-703
| -11% | -$39.7K |
|
515
Blue Owl Capital
OWL
$12.1B
| $327K | 0.02% |
28,103
-6,404
| -19% | -$74.6K |
|
516
Certara
CERT
$1.65B
| $326K | 0.02% |
+17,890
| New | +$326K |
|
517
DNOW Inc
DNOW
$1.61B
| $325K | 0.02% |
31,330
+15,297
| +95% | +$158K |
|
518
Revolution Medicines
RVMD
$7.56B
| $324K | 0.02% |
+12,100
| New | +$324K |
|
519
Insight Enterprises
NSIT
$3.96B
| $322K | 0.02% |
+2,203
| New | +$322K |
|
520
Cencora
COR
$57.4B
| $321K | 0.02% |
+1,670
| New | +$321K |
|
|
ANSS
521
DELISTED
Ansys
ANSS
| $321K | 0.02% |
973
+39
| +4% | +$12.9K |
|
|
NVRO
522
DELISTED
NEVRO CORP.
NVRO
| $321K | 0.02% |
+12,625
| New | +$321K |
|
523
Axcelis
ACLS
$2.62B
| $320K | 0.02% |
1,745
-635
| -27% | -$116K |
|
524
Clear Channel Outdoor Holdings
CCO
$631M
| $320K | 0.02% |
233,218
-5,110
| -2% | -$7K |
|
525
Otis Worldwide
OTIS
$34.4B
| $319K | 0.02% |
3,579
-853
| -19% | -$75.9K |
|